Colon polyp
Conditions
Interventions
LCI/CADe group: observation from the cecum to the rectum is performed using LCI mode with CADe (CAD EYE: Fujifilm Medical Corporation) assistance.
WLI group: observation from cecum to rectum with norm
Sponsors
Nippon Medical School Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. persons aged 20 years and over who undergo a planned colonoscopy. 2. persons undergoing colonoscopy with the purpose of examination as "asymptomatic patients, including second-line screening (screening)", "patients with a history of polypectomy and for follow-up purposes (surveillance)" or 'symptomatic scrutiny' 3. patients who do not wish to use or are clinically unable to use the antispasmodic drug butylscopolamine bromide (cardiac disease, history of angle closure glaucoma or glaucoma, benign prostatic hyperplasia, history of hyperthyroidism, drug allergy, etc.) 4. those who do not wish to use or are clinically unable to use the antispasmodic drug glucagon (e.g. history of diabetes, blood glucose and HbA1c not measured by blood sampling within 1 month of the examination and diabetes cannot be ruled out) 5. persons for whom the study has been explained in writing and written consent has been obtained.
Exclusion criteria
Exclusion criteria: 1. those with a history of inflammatory bowel disease 2. persons with active gastrointestinal bleeding 3. who have undergone bowel resection 4. those with a history of familial adenomatous polyposis 5. persons with previously known severe intestinal adhesions 6. any other person who is judged by the principal investigator or principal study investigator to be unsuitable to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adenoma detection rate | — |
Countries
Japan
Contacts
Public ContactTsugumi Habu
Nippon Medical School Hospital Department of Gastroenterology
Outcome results
None listed